Micron Sinks as CXMT's $8.55B IPO and HBM Export Fears Crack the Memory Supply Story

No Company News, a Whole Sector Lower

Micron didn't issue a single press release on July 15, yet the stock still fell roughly 7-8% intraday to about $903, and the HIP-3 perp printed a ~10% drawdown over 17 hours. This was a memory-complex de-rating, not a Micron-specific problem — the same session pulled Intel, AMD and Marvell lower as traders repriced the supply side of the DRAM and HBM market. Two things spooked the tape: Chinese memory maker ChangXin (CXMT) pursuing an $8.55 billion listing on Shanghai's STAR Market to fund a DRAM buildout, and fresh reporting that Washington is weighing more stringent unilateral curbs on high-bandwidth memory exports.

The Supply Side Got Loud All at Once

CXMT's raise landed hard because of timing: it's the third major capacity signal in barely a week. SK Hynix just raised $26.5 billion in its Nasdaq ADR debut, with a stated plan to expand output and equipment investment through 2030. Samsung and Hynix have collectively pledged hundreds of billions toward new fabs. Now a state-backed Chinese challenger is tapping public markets for another $8.55 billion. Every one of those dollars is future wafer supply, and it all lands directly against the thesis that has carried Micron this year — a structural HBM shortage. When three funding events cluster like this, the market stops pricing scarcity and starts pricing a glut, at least for a session.

The Export Knife Cuts Both Ways

The export angle is more double-edged than the headline reads. US rules already impose a presumption-of-denial license requirement on HBM shipments to China, and in June the Commerce Department extended AI-chip curbs to any company headquartered in China, closing the foreign-fab loophole. Three firms — SK Hynix, Samsung and Micron — control roughly 97% of HBM production, so tighter rules defend that oligopoly while simultaneously walling off a chunk of Chinese demand. And CXMT, for all the IPO noise, is restricted by those same sanctions from selling to American firms — so its near-term threat to Micron is commodity-DRAM pricing, not HBM share. The net is a regulatory overhang, not a fundamentals break.

Caught Between a $1,600 Target and Burry's Short

None of today moved the sell-side. Consensus still carries a Buy with an average target near $1,549 — Cantor Fitzgerald at $2,000, KeyBanc at $1,750 — and TD Cowen reiterated a $1,600 target just two days earlier, arguing the HBM shortage persists beyond 2027 with supply-commitment agreements already near 50% of revenue. Against all of that, Michael Burry is publicly short from $1,051.87, calling Micron a 'destroyer of capital' and noting free cash flow has been negative in nearly half its quarters. That is the whole trade in one line: a stock the sell-side models 60%+ higher, sitting well below its post-earnings high, with the loudest bear on the tape short and a week of supply headlines validating him. The perp is where that disagreement gets settled with size.